We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
1426
DELISTED
Vector Group Ltd.
VGR
| $5M | 0.01% |
498,920
-23,279
| -4% | -$232K |
|
|
TPTX
1427
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.99M | 0.01% |
63,996
+20,541
| +47% | +$1.52M |
|
1428
MGE Energy Inc
MGEE
$3.05B
| $4.99M | 0.01% |
66,967
-1,935
| -3% | -$144K |
|
1429
TechTarget
TTGT
$312M
| $4.98M | 0.01% |
64,286
-1,069
| -2% | -$76.7K |
|
1430
Horace Mann Educators
HMN
$2.19B
| $4.97M | 0.01% |
132,913
-6,556
| -5% | -$261K |
|
1431
Allison Transmission
ALSN
$9.64B
| $4.96M | 0.01% |
124,806
-12,327
| -9% | -$524K |
|
1432
Stewart Information Services
STC
$2.09B
| $4.96M | 0.01% |
87,490
-3,036
| -3% | -$177K |
|
|
OPI
1433
DELISTED
Office Properties Income Trust
OPI
| $4.94M | 0.01% |
168,411
-8,721
| -5% | -$250K |
|
|
MTOR
1434
DELISTED
MERITOR, Inc.
MTOR
| $4.93M | 0.01% |
210,731
-6,406
| -3% | -$168K |
|
|
QVCGA
1435
DELISTED
QVC Group Inc Series A
QVCGA
| $4.93M | 0.01% |
7,530
-875
| -10% | -$562K |
|
1436
Brookfield Renewable
BEPC
$6.19B
| $4.91M | 0.01% |
117,071
-71,914
| -38% | -$3.06M |
|
1437
CareDx
CDNA
$2.32B
| $4.9M | 0.01% |
53,540
-2,151
| -4% | -$171K |
|
1438
Greif
GEF
$5.07B
| $4.89M | 0.01% |
80,724
-1,759
| -2% | -$108K |
|
1439
Armstrong World Industries
AWI
$7.78B
| $4.88M | 0.01% |
45,537
-3,544
| -7% | -$365K |
|
1440
Agios Pharmaceuticals
AGIO
$1.91B
| $4.88M | 0.01% |
88,549
+19,331
| +28% | +$1.08M |
|
1441
TTM Technologies
TTMI
$14.2B
| $4.88M | 0.01% |
340,992
+2,964
| +0.9% | +$44.3K |
|
1442
ArcBest
ARCB
$3.02B
| $4.86M | 0.01% |
83,566
-5,248
| -6% | -$376K |
|
|
LMNX
1443
DELISTED
Luminex Corp
LMNX
| $4.85M | 0.01% |
131,697
-2,513
| -2% | -$91.4K |
|
|
CSII
1444
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.84M | 0.01% |
113,547
-4,387
| -4% | -$172K |
|
|
ESGR
1445
DELISTED
Enstar Group
ESGR
| $4.84M | 0.01% |
20,265
-216
| -1% | -$53.7K |
|
1446
Corcept Therapeutics
CORT
$11.7B
| $4.83M | 0.01% |
219,612
-3,832
| -2% | -$85.3K |
|
|
TRTN
1447
DELISTED
Triton International Limited
TRTN
| $4.83M | 0.01% |
92,235
+1,633
| +2% | +$86.5K |
|
|
CTEV
1448
Claritev Corp
CTEV
$458M
| $4.82M | 0.01% |
+12,658
| New | +$3.92M |
|
1449
Cohu
COHU
$2.45B
| $4.81M | 0.01% |
130,712
-12,364
| -9% | -$491K |
|
|
AL
1450
DELISTED
Air Lease Corp
AL
| $4.81M | 0.01% |
115,185
-5,391
| -4% | -$250K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.